Patents by Inventor Steven J. Burton

Steven J. Burton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240091690
    Abstract: According to the present disclosure, air cleaner assemblies, components, features, and methods relating thereto, are described. These features, in part, relate to configuration of a preferred seal arrangement and seal surface of the cartridge. Particular arrangements are shown, in which: the filter cartridge includes a seal arrangement having a axial pinch seal surface with a projection/recess contour including at least one projection thereon; and, the cartridge includes a seal contour projection stabilizing portion at a location in perimeter alignment with the portion of the seal pinch arrangement including the first housing engagement projection. Additional features are included that relate to clean air separator section tubes of a precleaner arrangement secured to a cartridge. These features can be used in cartridges including features outlined above, or in alternative cartridges. Additional features of air cleaner arrangements and filter cartridges in accord with the above are described.
    Type: Application
    Filed: September 28, 2023
    Publication date: March 21, 2024
    Inventors: Hubert J. Rahn, David J. Burton, Steven K. Campbell
  • Patent number: 8198407
    Abstract: The invention discloses methods for sequential protein isolation and purification from a biological sample by affinity chromatography. Affinity chromatography is conducted using ligands or ligand support complexes that selectively and specifically bind to proteins in the biological sample. The ligands or ligand support complexes were contacted sequentially in a predetermined order with the biological sample to allow each ligand or ligand-support complex to sequentially bind a protein from the biological sample.
    Type: Grant
    Filed: August 19, 2005
    Date of Patent: June 12, 2012
    Assignees: Prometic Biosciences, Ltd., The American National Red Cross
    Inventors: Steven J. Burton, Baldev Baines, John Curling, Christopher Bryant, David John Hammond, Dwun-Hou Chen, Timothy Keith Hayes
  • Patent number: 7510848
    Abstract: Prion protein binding materials and methods for using the binding materials to detect or remove a prion protein from a sample, such as a biological fluid or an environmental sample. The binding materials are capable of binding to one or more forms of prion protein including cellular prion protein (PrPc), infectious prion protein (PrPsc), recombinant prion protein (PrPr), and proteinase resistant prion protein (PrPres). Prions from various species, including humans and hamsters, are bound by the binding materials.
    Type: Grant
    Filed: October 13, 2004
    Date of Patent: March 31, 2009
    Assignees: North Carolina State University, Pathogen Removal and Diagnostic Technologies Inc.
    Inventors: David J. Hammond, Ruben G. Carbonell, Honglue Shen, Patrick V. Gurgel, Viterose Wiltshire-Lyerly, Steven J. Burton
  • Patent number: 7393658
    Abstract: Prion protein binding materials and methods for using the binding materials to detect or remove a prion protein from a sample, such as a biological fluid or an environmental sample. The binding materials are capable of binding to one or more forms of prion protein including cellular prion protein (PrPc), infectious prion protein (PrPsc), recombinant prion protein (PrPr), and proteinase resistant prion protein (PrPres). Prions from various species, including humans and hamsters, are bound by the binding materials.
    Type: Grant
    Filed: April 2, 2004
    Date of Patent: July 1, 2008
    Assignees: Pathogen Removal and Diagnostic Technologies, Inc., North Carolina State University
    Inventors: Ruben G. Carbonell, Honglue Shen, Patrick V. Gurgel, Viteros Wiltshire-Lyerly, David J. Hammond, Steven J. Burton
  • Patent number: 6034221
    Abstract: A process is provided for the preparation of albumin which has extremely low levels of or is essentially free of colorants, metal ions, human proteins, fragments of albumin, polymers or aggregates of albumin, and viruses, and which is relatively non-glycated, relatively high in free thiol and with an intact C-terminus. The process comprises passing albumin (preferably expressed and secreted by transformed yeast) through two chromatography purifications, ultrafiltering the product, passing through two further chromatography steps and again ultrafiltering the product.
    Type: Grant
    Filed: November 14, 1997
    Date of Patent: March 7, 2000
    Assignee: Delta Biotechnology Limited
    Inventors: Stephen Berezenko, John R. Woodrow, Richard A. Johnson, Patricia C. Wood, Steven J. Burton, Alan V. Quirk, David St. J. Coghlan, Mark J. Wilson
  • Patent number: 5728553
    Abstract: A process for the preparation of albumin which has extremely low levels of or is essentially free of colorants, metal ions, human proteins, fragments of albumin, polymers or aggregates of albumin, and viruses, and which is relatively non-glycated, relatively high in free thiol and with an intact C-terminus. The process comprises passing albumin (preferably expressed and secreted by transformed yeast) through two chromatography purifications, ultrafiltering the product, passing through two further chromatography steps and again ultrafiltering the product.
    Type: Grant
    Filed: May 25, 1995
    Date of Patent: March 17, 1998
    Assignee: Delta Biotechnology Limited
    Inventors: Andrew R. Goodey, Darrell Sleep, Hendrik van Urk, Stephen Berezenko, John R. Woodrow, Richard A. Johnson, Patricia C. Wood, Steven J. Burton, Alan V. Quirk, David St. J. Coghlan, Mark J. Wilson
  • Patent number: 4864018
    Abstract: A compound of the formula: ##STR1## wherein X is a non-chromophoric bridging group which provides at least three single covalent bonds between Ring B and the group R;R is a group containing a reactive halogen atom; andeach A independently is H or an acidic group;provided that the molecule contains sufficient acidic groups to render it water soluble and then when X provides only 3 covalent bonds between Ring B and R, the latter is not a chlorodifuoropyrimidyl group, which is suitable for the preparation of a protein adsorbent or precipitant for use in the separation of mixtures of proteins.
    Type: Grant
    Filed: July 14, 1986
    Date of Patent: September 5, 1989
    Assignee: Imperial Chemical Industries PLC
    Inventors: Cecil V. Stead, Steven J. Burton, Christopher R. Lowe
  • Patent number: 4851528
    Abstract: A water-soluble anthraquinone compound of the formula: ##STR1## wherein A represents a divalent hydrocarbon group;X represents a divalent hydrocarbon group; andR.sup.1 & R.sup.2 each independently is H or alkyl or together, with X and the N atoms to which they are attached, represent a diazaheterocycle;R represents a monovalent hydrocarbon group;n is 0 or 1;Z is H or a group, Y--B;Y is a divalent heterocycle; andB is an activated halogen atom, and an adduct thereof with a carbohydrate substrate, capable of selectively absorbing certain proteinaceous materials and suitable for use in the chromatographic separation of proteins.
    Type: Grant
    Filed: August 27, 1986
    Date of Patent: July 25, 1989
    Assignee: Imperial Chemical Industries PLC
    Inventors: Cecil V. Stead, Steven J. Burton, Christopher R. Lowe